Effectiveness of the Education Program on Increasing the Competency Level of Health Cadres in Indonesia

November 15, 2023 updated by: Dewie Sulistyorini, Hiroshima University

Ending preventable maternal mortality (EPMM): By 2030, every country should reduce its maternal mortality ratio (MMR) by at least two-thirds from the 2010 baseline. In the era of the SDGs, an acceleration of current progress is required to achieve SGD target 3.1, working towards a vision of ending all preventable maternal mortality. In Central Java, one of the most effective efforts to reduce maternal mortality is increasing the number of human resources, who can assist pregnant mothers and supervise their period of pregnancy. The maternal mortality rate (MMR) in Banjarnegara Regency in 2021 is 287.05 per 100,000 live births, this indicates the top 10 in Central Java Province over the past 5 years. Health cadres, who are non-professional volunteer health supporters for pregnant women appointed by regional public health centers (PHCs), are expected to be the key human resources who contribute to reducing MMR in Indonesia and Banjarnegara Regency as well. However, based on an initial study by researchers conducting qualitative research with focus group discussions (FGDs) and in-depth interviews in April-July 2023, researchers found that health cadres had incorrect and unscientific knowledge. Therefore, improving the knowledge and skills of the health cadres through education programs could be expected to further improve the health outcomes of pregnant women, consequently contributing to reducing the MMR.

The purpose of this study is to improve health cadres' competency level in monitoring the risks of pregnant women. This monitoring activities for pregnant women by cadres is an effort to prevent maternal mortality, because if there are complications they can be treated as early as possible.

Study Overview

Detailed Description

  1. Prior to the commencement of the study, the PI will visit the selected PHCs as the intervention group and control group, and then explain an overview of this study. The PI obtained the agreement to participate in this study from the head of the PHC.
  2. The PI will ask the coordinator midwife at each PHC to introduce the names and phone numbers of the health cadres who will be potential participants. The PI and the researchers will contact each potential participant one by one to explain the procedure of this study and then obtain their consent to become a participant in this study. Cadres who belong to PHCs will receive the competency-based education program, and those who belong to PHCs allocated to the control group will follow the initial orientation provided by the PHC.
  3. The PI and assistant (research team) will create a WhatsApp group for the intervention group and control group, and then distribute the questionnaires at an initial stage. All data will be collected at each PHC where the study will be conducted.

Study Type

Interventional

Enrollment (Estimated)

132

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Currently working as a health care for at least 1 year
  2. Domiciled in the local area
  3. Able to operate a telephone
  4. Those who agreed to give consent and are willing to participate in the study
  5. Those who agreed to receive the health education program and participate in the whole evaluation process.

Exclusion Criteria:

  1. Those who are planning to move out to another city during the study period.
  2. Those who are no longer work as a health cadre.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC .The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).
The intervention group will receive the competency-based education program for 1 month at each PHC, after baseline data collection. The education program will be conducted weekly. This education session will be conducted for 4 hours per session, with 20 health cadres in a group per PHC. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score at the 2nd post-assessment (2 months after being given the education program).
Experimental: control
Health cadres in the control group have received the initial orientation from the PHCs. In this study, they take only the competency questionnaires including skill check will be collected following the data collection timeline. After completing the research, the control group will receive the education program material used for the intervention group if they require.
the initial orientation from the PHCs

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The competency level of health cadres
Time Frame: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
Competency is operationally defined as the ability to integrate components of knowledge, skills, values, and attitudes into practice, and build a trusting relationship with and guide a pregnant woman and her surroundings for them to take evidence-based appropriate behavior. The competency level is measured by the researcher developing a competency questionnaire which consists of a knowledge test, skill, and attitude checklist score
baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The knowledge test scores of health cadres
Time Frame: baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
researcher developing knowledge questionnaire
baseline (T0), after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
The health assessment skills checklist score of health cadres
Time Frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
researcher developing health assessment skills checklist
after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
The communication skills checklist score of health cadres
Time Frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
researcher developing communication skills checklist
after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
The confidence score of health cadres
Time Frame: after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
researcher developing communication skills checklist
after 1 month from the baseline (T1) and after 3 months from the baseline (T2)
The satisfaction score of health cadres
Time Frame: after 1 month from the baseline (T1)
researcher developing satisfaction skills checklist
after 1 month from the baseline (T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dewie Sulistyorini, Hiroshima University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 27, 2023

Primary Completion (Estimated)

March 27, 2024

Study Completion (Estimated)

April 7, 2024

Study Registration Dates

First Submitted

November 12, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Estimated)

November 16, 2023

Study Record Updates

Last Update Posted (Estimated)

November 17, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Share according to request to the PI and researcher

IPD Sharing Time Frame

April 2025 - April 2026

IPD Sharing Access Criteria

dewiesulistyorini@gmail.com

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Maternal Mortality

Clinical Trials on The education program

3
Subscribe